When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
YGMZ - Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga
MingZhu Logistics Holdings Limited
Gainers
Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.
Eargo, Inc. (NASDAQ: EAR) shares climbed 50.4% to $2.5274 after the company announced it will be taken private by Patient Square Capital.
VYNE Therapeutics Inc. (NASDAQ: VYNE) gained 39.9% to $3.1399 after the company announced a private placement of $88 million and data from its Phase 1b trial evaluating once-daily dosing of VYN201 in patients with nonsegmental vitiligo.
Conduit Pharmaceuticals Inc. (NASDAQ: CDT) shares gained 27.9% to $1.3042 after falling more than 12% on Friday.
HeartCore Enterprises, Inc. (NASDAQ: HTCR) surged 24% to $0.7718. Heartcore Enterprises recently entered into at-market offering agreement for an at-market offering with H.C. Wainwright & Co.
ImmunityBio, Inc. (NASDAQ: IBRX) gained 19.4% to $2.9600. The FDA recently accepted ImmunityBio's resubmission of its Biologics License Application for N-803 as complete.
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares climbed 16.8% to $3.0850. Coherus and Junshi Biosciences reported FDA approval of LOQTORZI in all lines of treatment for recurrent or metastatic nasopharyngeal carcinoma.
Aemetis, Inc. (NASDAQ: AMTX) gained 16.5% to $5.02. Aemetis received $150 million biodiesel supply allocation from India oil marketing companies.
JinkoSolar Holding Co., Ltd. (NYSE: JKS) surged 16% to $30.01 following better-than-expected quarterly results.
Akerna Corp. (NASDAQ: KERN) jumped 16% to $0.3550.
MeiraGTx Holdings plc (NASDAQ: MGTX) rose 16% to $4.29. MeiraGTx announced a $30 million strategic investment from Sanofi via purchase of 4 million shares at $7.50 per share.